Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Georg W. Herget, Felix Kälberer, Gabriele Ihorst, Giulia Graziani, Lukas Klein, Michael Rassner, Christian Gehler, Johannes Jung, Hagen Schmal, Ralph Wäsch & Monika Engelhardt. (2021) Interdisciplinary approach to multiple myeloma – time to diagnosis and warning signs. Leukemia & Lymphoma 62:4, pages 891-898.
Read now
Read now
Giulia Graziani, Georg W. Herget, Gabriele Ihorst, Mara Zeissig, Aristeidis Chaidos, Holger W. Auner, Justus Duyster, Ralph Wäsch & Monika Engelhardt. (2020) Time from first symptom onset to the final diagnosis of multiple myeloma (MM) – possible risks and future solutions: retrospective and prospective ‘Deutsche Studiengruppe MM’ (DSMM) and ‘European Myeloma Network’ (EMN) analysis. Leukemia & Lymphoma 61:4, pages 875-886.
Read now
Read now
Yeh-Ku Chen, Shao-Min Han, Youngsen Yang, Tseng-Hsi Lin, Huey-En Tzeng, Kuang-Hsi Chang, Wen-Li Hwang & Chieh-Lin Jerry Teng. (2016) Early mortality in multiple myeloma: Experiences from a single institution. Hematology 21:7, pages 392-398.
Read now
Read now
Articles from other publishers (45)
Rohit Vijjhalwar, Kaiyang Song, Roshi Shrestha, Stella Bowcock, Maria T. Sanchez-Santos, Karthik Ramasamy & Muhammad Kassim Javaid. (2023) Patient-reported symptoms and diagnostic journey in Multiple Myeloma. Frontiers in Oncology 13.
Crossref
Crossref
Yuliia Sereda, Fernando Alarid-Escudero, Nina A Bickell, Su-Hsin Chang, Graham A Colditz, Chin Hur, Hawre Jalal, Evan R Myers, Tracy M Layne, Shi-Yi Wang, Jennifer M Yeh, Thomas A Trikalinos, Yuliia Sereda, Fernando Alarid-Escudero, Nina A Bickell, Su-Hsin Chang, Graham A Colditz, Chin Hur, Hawre Jalal, Evan R Myers, Tracy M Layne, Shi-Yi Wang, Jennifer M Yeh & Thomas A Trikalinos. (2023) Approaches to developing de novo cancer population models to examine questions about cancer and race in bladder, gastric, and endometrial cancer and multiple myeloma: the Cancer Intervention and Surveillance Modeling Network incubator program. JNCI Monographs 2023:62, pages 219-230.
Crossref
Crossref
Hamlet Gasoyan, Mark A. Fiala, Michelle Doering, Ravi Vij, Michael Halpern & Graham A. Colditz. (2023) Disparities in Multiple Myeloma Treatment Patterns in the United States: A Systematic Review. Clinical Lymphoma Myeloma and Leukemia 23:11, pages e420-e427.
Crossref
Crossref
Stella Bowcock, Catherine Atkin, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Richard D. Neal, Tim Planche, Kamaraj Karunanithi, Stephen Jenkins, Simon Stern, Sarah Arnott, Peter Toth, Farooq Wandroo, Janet Dunn & Mark T. Drayson. (2023) Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial. Cancers 15:13, pages 3337.
Crossref
Crossref
Andiswa M. Pooe, Abegail N. Dlova & Sam T. Ntuli. (2023) Medical practitioners’ knowledge and awareness of multiple myeloma at public hospitals, Gauteng, South Africa. South African Family Practice 65:1.
Crossref
Crossref
Aisling O'Brien, Alison Bransfield, Fiona O'Halloran & Vitaliy Mykytiv. (2023) Calculated Globulin as a potential screening tool for paraproteinemia to aid in the early diagnosis of Multiple Myeloma. Clinical Biochemistry 116, pages 113-119.
Crossref
Crossref
Yanjie Zhang, Juan Pan, Haixin Kang, Shuotao Peng, Tao-Hsin Tung & Bo Shen. (2023) Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments. Annals of Hematology 102:4, pages 801-809.
Crossref
Crossref
Marta Morawska, Jadwiga Dwilewicz-Trojaczek, Tomasz Stompór, Piotr Ligocki, Marek Stopiński, Michał Sutkowski, Norbert Grząśko, Anna Kordecka, Mariusz Kordecki, Artur Jurczyszyn, Dominik Dytfeld, Tomasz Wróbel, Krzysztof Jamroziak, Agnieszka Druzd-Sitek, Adam Walter-Croneck & Krzysztof Giannopoulos. (2023) A Stepwise Screening Protocol for Multiple Myeloma. Journal of Clinical Medicine 12:4, pages 1345.
Crossref
Crossref
Georgia B. Black, Laura Boswell, Jenny Harris & Katriina L. Whitaker. (2023) What causes delays in diagnosing blood cancers? A rapid review of the evidence. Primary Health Care Research & Development 24.
Crossref
Crossref
Joseph Mikhael, Manisha Bhutani & Craig E. Cole. (2023) Multiple Myeloma for the Primary Care Provider: A Practical Review to Promote Earlier Diagnosis Among Diverse Populations. The American Journal of Medicine 136:1, pages 33-41.
Crossref
Crossref
Haris Hatic, Shealeigh Inselman, Jonathan Inselman, Anuhya Kommalapati, Sri Harsha Tella, Jonas Paludo, Urshila Durani, Ronald S. Go & Gaurav Goyal. (2022) Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM). Leukemia Research 123, pages 106966.
Crossref
Crossref
Daniel Jones, Erica Di Martino, Stephen H Bradley, Blessing Essang, Scott Hemphill, Judy M Wright, Cristina Renzi, Claire Surr, Andrew Clegg & Richard Neal. (2022) Factors influencing symptom appraisal and help-seeking of older adults with possible cancer: a mixed-methods systematic review. British Journal of General Practice 72:723, pages e702-e712.
Crossref
Crossref
Daniel Jones, Erica Di Martino, Stephen H Bradley, Blessing Essang, Scott Hemphill, Judy M Wright, Cristina Renzi, Claire Surr, Andrew Clegg, Niek De Wit & Richard Neal. (2022) Factors affecting the decision to investigate older adults with potential cancer symptoms: a systematic review. British Journal of General Practice 72:714, pages e1-e10.
Crossref
Crossref
Anouchka Seesaghur, Natalia Petruski-Ivleva, Victoria Louise Banks, Jocelyn Ruoyi Wang, Ali Abbasi, David Neasham & Karthik Ramasamy. (2021) Clinical features and diagnosis of multiple myeloma: a population-based cohort study in primary care. BMJ Open 11:10, pages e052759.
Crossref
Crossref
Xin Zhou, Yan Lu, Jun Xia, Jingjue Mao, Jing Wang & Hongfeng Guo. (2021) Association between baseline Controlling Nutritional Status score and clinical outcomes of patients with multiple myeloma. Cancer Biomarkers 32:1, pages 65-71.
Crossref
Crossref
Colleen Webber, Marlo Whitehead, Andrea Eisen, Claire M. B. Holloway & Patti A. Groome. (2021) Factors associated with waiting time to breast cancer diagnosis among symptomatic breast cancer patients: a population-based study from Ontario, Canada. Breast Cancer Research and Treatment 187:1, pages 225-235.
Crossref
Crossref
Alex Fauer, Sung Won Choi, Lauren P. Wallner, Matthew A. Davis & Christopher R. Friese. (2021) Understanding quality and equity: patient experiences with care in older adults diagnosed with hematologic malignancies. Cancer Causes & Control 32:4, pages 379-389.
Crossref
Crossref
Antonieta Medina-Lara, Bogdan Grigore, Ruth Lewis, Jaime Peters, Sarah Price, Paolo Landa, Sophie Robinson, Richard Neal, William Hamilton & Anne E Spencer. (2020) Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis. Health Technology Assessment 24:66, pages 1-332.
Crossref
Crossref
Raquel Oliveros Conejero, Pilar Pascual Usandizaga & Adolfo Garrido Chércoles. (2020) Optimization of workflow and screening panels for the detection of malignant monoclonal gammopathies. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 1:3.
Crossref
Crossref
Raquel Oliveros Conejero, Pilar Pascual Usandizaga & Adolfo Garrido Chércoles. (2020) Optimización de flujos de trabajo y paneles de cribado para la detección de gammapatias monoclonales malignas. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 1:3.
Crossref
Crossref
Stefania Raimondo, Ornella Urzì, Alice Conigliaro, Lavinia Raimondi, Nicola Amodio & Riccardo Alessandro. (2020) Emerging Insights on the Biological Impact of Extracellular Vesicle-Associated ncRNAs in Multiple Myeloma. Non-Coding RNA 6:3, pages 30.
Crossref
Crossref
Vivek Kumar, Muhamad Alhaj-Moustafa, Leyla Bojanini, Taimur Sher, Vivek Roy, Rami Manochakian, Prakash Vishnu, Srilekha Bodepudi, Zan Shareef, Salman Ahmed, Prachi Jani, Aneel Paulus, Ashna Grover, Victoria R. Alegria, Meghna Ailawadhi, Asher Chanan-Khan & Sikander Ailawadhi. (2020) Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient Care. JCO Oncology Practice 16:4, pages e341-e349.
Crossref
Crossref
Cristina Renzi, Aradhna Kaushal, Jon Emery, Willie Hamilton, Richard D. Neal, Bernard Rachet, Greg Rubin, Hardeep Singh, Fiona M. Walter, Niek J. de Wit & Georgios Lyratzopoulos. (2019) Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms. Nature Reviews Clinical Oncology 16:12, pages 746-761.
Crossref
Crossref
Krzysztof Giannopoulos, Jadwiga Dwilewicz-Trojaczek, Tomasz Stompór, Piotr Ligocki, Marek Stopiński, Michał Sutkowski, Norbert Grząśko, Marta Morawska, Anna Kordecka, Mariusz Kordecki, Artur Jurczyszyn, Dominik Dytfeld, Tomasz Wróbel, Krzysztof Jamroziak, Agnieszka Druzd-Sitek, Adam Walter-Croneck & Anna Dmoszyńska. (2019) Wyzwania wczesnej diagnostyki szpiczaka plazmocytowego – algorytm diagnostyczny. Acta Haematologica Polonica 50:3, pages 121-129.
Crossref
Crossref
Austėja Dapkevičiūtė, Virginijus Šapoka, Elena Martynova & Valdas Pečeliūnas. (2019) Time from Symptom Onset to Diagnosis and Treatment among Haematological Malignancies: Influencing Factors and Associated Negative Outcomes. Medicina 55:6, pages 238.
Crossref
Crossref
Constantinos Koshiaris. (2019) Methods for reducing delays in the diagnosis of multiple myeloma. International Journal of Hematologic Oncology 8:1, pages IJH13.
Crossref
Crossref
Constantinos Koshiaris, Ann Van den Bruel, Jason L Oke, Brian D Nicholson, Elizabeth Shephard, Mick Braddick & William Hamilton. (2018) Early detection of multiple myeloma in primary care using blood tests: a case–control study in primary care. British Journal of General Practice 68:674, pages e586-e593.
Crossref
Crossref
Jun Xia, Lingling Wang, Xin Zhou, Jing Wang, Huan Wang & Hongfeng Guo. (2018) Early mortality in elderly patients undergoing treatment for multiple myeloma in real-world practice. Journal of International Medical Research 46:6, pages 2230-2237.
Crossref
Crossref
Debra Howell, Alexandra Smith, Simon Appleton, Timothy Bagguley, Una Macleod, Gordon Cook, Russell Patmore & Eve Roman. (2017) Multiple myeloma: routes to diagnosis, clinical characteristics and survival - findings from a UK population-based study. British Journal of Haematology 177:1, pages 67-71.
Crossref
Crossref
John P. Campbell, Jennifer L.J. Heaney, Meena Shemar, Dene Baldwin, Ann E. Griffin, Emma Oldridge, Margaret Goodall, Zaheer Afzal, Tim Plant, Mark Cobbold, Roy Jefferis, Joannes F.M. Jacobs, Christopher Hand & Mark T. Drayson. (2017) Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool. Clinical Chemistry and Laboratory Medicine (CCLM) 55:3.
Crossref
Crossref
Jia-Hong Chen, Chi-Hsiang Chung, Yung-Chih Wang, Shun-Neng Hsu, Wen-Yen Huang & Wu-Chien Chien. (2016) Prevalence and Mortality-Related Factors of Multiple Myeloma in Taiwan. PLOS ONE 11:12, pages e0167227.
Crossref
Crossref
Charlotte Pawlyn, Francesca Gay, Alessandra Larocca, Vivek Roy & Sikander Ailawadhi. (2016) Nuances in the Management of Older People With Multiple Myeloma. Current Hematologic Malignancy Reports 11:3, pages 241-251.
Crossref
Crossref
Chih-Chun Chang, Ming-Jang Su, Jung-Li Ho, Jen-Tang Sun, Huang-Wen Tsai, Hui-Fei Tang & Fang-Yeh Chu. (2016) Proactive Consultation by a Clinical Pathologist Prevents Diagnostic Delay in Hematological Malignancies. Asian Pacific Journal of Cancer Prevention 17:3, pages 1019-1022.
Crossref
Crossref
Elizabeth A Shephard, Richard D Neal, Peter W Rose, Fiona M Walter & William T Hamilton. (2015) Quantifying the risk of non-Hodgkin lymphoma in symptomatic primary care patients aged ≥40 years: a large case–control study using electronic records. British Journal of General Practice 65:634, pages e281-e288.
Crossref
Crossref
R D Neal, P Tharmanathan, B France, N U Din, S Cotton, J Fallon-Ferguson, W Hamilton, A Hendry, M Hendry, R Lewis, U Macleod, E D Mitchell, M Pickett, T Rai, K Shaw, N Stuart, M L Tørring, C Wilkinson, B Williams, N Williams & J Emery. (2015) Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. British Journal of Cancer 112:S1, pages S92-S107.
Crossref
Crossref
Nicole M Engel-Nitz, Benjamin Eckert, Rui Song, Priyanka Koka, Erin M Hulbert, Jeffrey McPheeters & April Teitelbaum. (2014) Diagnostic testing managed by hematopathology specialty and other laboratories: costs and patient diagnostic outcomes. BMC Clinical Pathology 14:1.
Crossref
Crossref
Gergely Varga, Gábor Mikala, Hajnalka Andrikovics & Tamás Masszi. (2014) How long does a myeloma patient currently wait for the diagnosis in Hungary?. Orvosi Hetilap 155:39, pages 1538-1543.
Crossref
Crossref
Debra A Howell, Alexandra G Smith, Andrew Jack, Russell Patmore, Una Macleod, Emma Mironska & Eve Roman. (2013) Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network. BMC Blood Disorders 13:1.
Crossref
Crossref
Kathy L. Schulman, Karina Berenson, Ya-Chen (Tina) Shih, Kathleen A. Foley, Arijit Ganguli, Jonas de Souza, Nicholas A. Yaghmour & Alex Shteynshlyuger. (2013) A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report of the ISPOR Oncology Good Outcomes Research Practices Working Group. Value in Health 16:4, pages 655-669.
Crossref
Crossref
Stephanie Stringer, Mark Cook & Paul Cockwell. (2012) Achieving an Early Myeloma Response in Patients With Kidney Impairment. Advances in Chronic Kidney Disease 19:5, pages 303-311.
Crossref
Crossref
Gregory A. Abel, Christopher R. Friese, Bridget A. Neville, Katherine M. Wilson, B. Taylor Hastings, Craig C. Earle, Nancy L. Keating & Lisa C. Richardson. (2012) Referrals for suspected hematologic malignancy: A survey of primary care physicians. American Journal of Hematology 87:6, pages 634-636.
Crossref
Crossref
Giada Bianchi & Irene M. Ghobrial. (2012) Does My Patient with a Serum Monoclonal Spike have Multiple Myeloma?. Hematology/Oncology Clinics of North America 26:2, pages 383-393.
Crossref
Crossref
Sheng-Hsiang Yang, Hao-Wei Teng, Ying-Chung Hong, Chun-Yu Liu, Yuan-Bin Yu, Ching-Fen Yang, Jyh-Pyng Gau, Jin-Hwang Liu, Tai-Jay Chang, Jeffrey J. Y. Yen, Po-Min Chen, Tzeon-Jye Chiou, Cheng-Hwai Tzeng & Liang-Tsai Hsiao. (2011) International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents. Annals of Hematology 91:1, pages 93-102.
Crossref
Crossref
A Smith, D Howell, R Patmore, A Jack & E Roman. (2011) Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. British Journal of Cancer 105:11, pages 1684-1692.
Crossref
Crossref
Christopher R. Friese, Craig C. Earle, Lysa S. Magazu, Jennifer R. Brown, Bridget A. Neville, Nathanael D. Hevelone, Lisa C. Richardson & Gregory A. Abel. (2010) Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia. Cancer 117:7, pages 1470-1477.
Crossref
Crossref